Delirium in critically ill patients can be reduced with statins
January 21st 2014Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission, according to a study published online ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Read More
Online patient portal boosts diabetes medication adherence
January 20th 2014Diabetic patients who used an online patient portal to refill medications increased their medication adherence and improved cholesterol levels, according to a Kaiser Permanente study published in a recent issue of Medical Care.
Read More
Antibiotic misuse problematic for adult emergency room patients
January 20th 2014An analysis of emergency department (ED) visits over a 10-year period found that while inappropriate antibiotic use is decreasing in pediatric settings, it continues to remain a problem in adults, according to a study published ahead of print in Antimicrobial Agents and Chemotherapy.
Read More
Fulyzaq improves noninfectious diarrhea in patients with HIV on ART therapy
January 20th 2014Noninfectious diarrhea in patients with HIV on antiretroviral therapy showed improvement after treatment with 125-mg delayed-release crofelemer (Fulyzaq, Salix Pharmaceuticals) tablets, according to a study in HIV Clinical Trials.
Read More
Optimal adherence to meds prescribed post-heart attack lowers hospital readmissions
January 17th 2014Optimal medication adherence is important for patients who have had a heart attack in order to get maximum clinical benefit, according to a study published in the January 2014 issue of the American Heart Journal.
Read More
In elderly patients with chronic lymphocytic leukemia (CLL) taking obinutuzumab (Gazyva, Genentech), also known as GA101, in combination with chlorambucil lived nearly 1 year longer without worsening of their disease compared to rituximab in combination with chlorambucil, according to a study published online ahead of print in the New England Journal of Medicine.
Read More
Drugs in Perspective: Takeda's and Lundbeck’s Brintellix
January 9th 2014Major depressive disorder (MDD) is a medical illness that is characterized by depressed mood, hopelessness, and loss of interest.1 According to the National Institute of Mental Health (NIMH), approximately 6.7% of US adult population experienced MDD, with 30.4% of these cases (2.0% of U.S. adult population) classified as severe.
Read More
Updated data with oral proteasome inhibitor reported in newly diagnosed multiple myeloma patients
January 9th 2014An investigational all-oral proteasome inhibitor-MLN9708 (Millennium: The Takeda Oncology Company)-plus lenalidomide and dexamethasone generated high response rates and increased depth of response with extended treatment duration in newly diagnosed multiple myeloma patients, according to data presented at the American Society of Hematology (ASH) 2013 annual meeting in New Orleans.
Read More
Baxter voluntarily recalls select lots of premix parenteral nutrition
January 7th 2014Baxter International has initiated a voluntary recall in the United States of 2 lots of premixed sterile intravenous (IV) parenteral nutrition products: CLINIMIX (Amino Acid in Dextrose) Injection and CLINIMIX E (Amino Acid with Electrolytes in Dextrose with Calcium) Injections to the user level because of complaints of particulate matter found in the products.
Read More